Medical Market Report

Global Intra-Uterine Contraceptive Devices Market By Type (Copper IUCD, and Hormonal IUCD), By Application (Hospitals, Gynaecology clinics, and Community healthcare), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 136671
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Intra-Uterine Contraceptive Devices Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global intra-uterine contraceptive devices market is segmented on the basis of Type, Application, and geography.

    The Global Intra-Uterine Contraceptive Devices market is estimated to be US$ XX.X Mn in 2019 and is projected to increase significantly at a CAGR of x.x% from 2020 to 2028.

    Intra-Uterine Contraceptive Devices Market Scope:

    By type, the market is segmented into Copper IUCD, and Hormonal IUCD. By Application, the market is divided into Hospitals, Gynaecology clinics, and Community healthcare.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Bayer AG, Teva Pharmaceuticals Industries, Mona Lisa N.V., DKT International, Egemen International, Melbea AG, Melbea AG, Pregna International Limited, Medical Engineering Corporation SA, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd China RH Contraceptives Co. Ltd, Sanghai Jolly Medical Education Co. Ltd, Bernstein Leibhard LLP, Zheijang Daji Medical Instruments Ltd., Nimble International, AME Line Technico, Cepeo, Contraceptivos, Injeflex Ind And Com Ltda, and Bersil.

    Key Market Segments

    Type

    Copper IUCD
    Hormonal IUCD

    Application

    Hospitals
    Gynaecology clinics
    Community healthcare

    Key Market Players included in the report:

    Bayer AG
    Teva Pharmaceuticals Industries
    Mona Lisa N.V.
    DKT International
    Egemen International
    Melbea AG
    Melbea AG
    Pregna International Limited
    Medical Engineering Corporation SA
    SMB Corporation and Meril Life Sciences Pvt. Ltd.
    Medu Scientific Ltd China RH Contraceptives Co. Ltd
    Sanghai Jolly Medical Education Co. Ltd
    Bernstein Leibhard LLP
    Zheijang Daji Medical Instruments Ltd.
    Nimble International
    AME Line Technico
    Cepeo
    Contraceptivos
    Injeflex Ind And Com Ltda
    Bersil

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Intra-Uterine Contraceptive Devices Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Intra-Uterine Contraceptive Devices Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Intra-Uterine Contraceptive Devices Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Intra-Uterine Contraceptive Devices Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Intra-Uterine Contraceptive Devices Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Intra-Uterine Contraceptive Devices Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Intra-Uterine Contraceptive Devices sub-markets, depending on key regions (various vital states).
    To analyze Intra-Uterine Contraceptive Devices Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Intra-Uterine Contraceptive Devices Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2014 to 2019, and also prediction to 2028.
    Primary worldwide Intra-Uterine Contraceptive Devices Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Intra-Uterine Contraceptive Devices Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global Intra-Uterine Contraceptive Devices Market Overview
    

    3.1. Intra-Uterine Contraceptive Devices Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy4. Global Intra-Uterine Contraceptive Devices Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Intra-Uterine Contraceptive Devices Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Copper IUCD
    

      4.4. Hormonal IUCD5. Global Intra-Uterine Contraceptive Devices Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Intra-Uterine Contraceptive Devices Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Hospitals
    

      5.4. Gynaecology clinics
    

      5.5. Community healthcare6. Global Intra-Uterine Contraceptive Devices Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Intra-Uterine Contraceptive Devices Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Intra-Uterine Contraceptive Devices Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Intra-Uterine Contraceptive Devices Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Intra-Uterine Contraceptive Devices Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Intra-Uterine Contraceptive Devices Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global Intra-Uterine Contraceptive Devices Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Bayer AG
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. Teva Pharmaceuticals Industries
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. Mona Lisa N.V.
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments  7.6. DKT International
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. Egemen International
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. Melbea AG
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments  7.9. Melbea AG
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments  7.10. Pregna International Limited
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments  7.11. Medical Engineering Corporation SA
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments  7.12. SMB Corporation and Meril Life Sciences Pvt. Ltd.
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments  7.13. Medu Scientific Ltd China RH Contraceptives Co. Ltd
    

        7.13.1. Company Overview
    
    7.13.2. Financial Highlights
    
    7.13.3. Product Portfolio
    
    7.13.4. SWOT Analysis
    
    7.13.5. Key Strategies and Developments  7.14. Sanghai Jolly Medical Education Co. Ltd
    

        7.14.1. Company Overview
    
    7.14.2. Financial Highlights
    
    7.14.3. Product Portfolio
    
    7.14.4. SWOT Analysis
    
    7.14.5. Key Strategies and Developments  7.15. Bernstein Leibhard LLP
    

        7.15.1. Company Overview
    
    7.15.2. Financial Highlights
    
    7.15.3. Product Portfolio
    
    7.15.4. SWOT Analysis
    
    7.15.5. Key Strategies and Developments  7.16. Zheijang Daji Medical Instruments Ltd.
    

        7.16.1. Company Overview
    
    7.16.2. Financial Highlights
    
    7.16.3. Product Portfolio
    
    7.16.4. SWOT Analysis
    
    7.16.5. Key Strategies and Developments  7.17. Nimble International
    

        7.17.1. Company Overview
    
    7.17.2. Financial Highlights
    
    7.17.3. Product Portfolio
    
    7.17.4. SWOT Analysis
    
    7.17.5. Key Strategies and Developments  7.18. AME Line Technico
    

        7.18.1. Company Overview
    
    7.18.2. Financial Highlights
    
    7.18.3. Product Portfolio
    
    7.18.4. SWOT Analysis
    
    7.18.5. Key Strategies and Developments  7.19. Cepeo
    

        7.19.1. Company Overview
    
    7.19.2. Financial Highlights
    
    7.19.3. Product Portfolio
    
    7.19.4. SWOT Analysis
    
    7.19.5. Key Strategies and Developments  7.20. Contraceptivos
    

        7.20.1. Company Overview
    
    7.20.2. Financial Highlights
    
    7.20.3. Product Portfolio
    
    7.20.4. SWOT Analysis
    
    7.20.5. Key Strategies and Developments  7.21. Injeflex Ind And Com Ltda
    

        7.21.1. Company Overview
    
    7.21.2. Financial Highlights
    
    7.21.3. Product Portfolio
    
    7.21.4. SWOT Analysis
    
    7.21.5. Key Strategies and Developments  7.22. Bersil
    

        7.22.1. Company Overview
    
    7.22.2. Financial Highlights
    
    7.22.3. Product Portfolio
    
    7.22.4. SWOT Analysis
    
    7.22.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.